229
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

The Impact of Obesity on the Host–Pathogen Interaction with Influenza Viruses – Novel Insights: Narrative Review

ORCID Icon, , , , & ORCID Icon
Pages 769-777 | Received 30 Aug 2023, Accepted 10 Jan 2024, Published online: 12 Feb 2024

References

  • World Health Organization. Obesity and overweight 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed August 8, 2023.
  • Gutierrez-Gonzalez E, Garcia-Solano M, Pastor-Barriuso R, et al. Socio-geographical disparities of obesity and excess weight in adults in Spain: insights from the ENE-COVID study. Front Public Health. 2023;11:1195249. doi:10.3389/fpubh.2023.1195249
  • Brady TM. Obesity-Related Hypertension in Children. Front Pediatr. 2017;5:197. doi:10.3389/fped.2017.00197
  • Miron VD, Bar G, Filimon C, Gaidamut VA, Craiu M. Monitoring of excess body weight in children in the emergency department of a tertiary pediatric hospital in Bucharest, Romania. Maedica. 2021;16(3):389–393. doi:10.26574/maedica.2021.16.3.389
  • European Centre for Disease Prevention and Control. Risk groups for severe influenza 2023. Available from: https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/risk-groups. Accessed August 10, 2023.
  • World Health Organization. Vaccines against influenza: WHO position paper, May 2022. Weekly Epidemiological Rec. 2022;19:185–208.
  • Centers for Disease Control and Prevention. People at Higher Risk of Flu Complications 2023. Available from: https://www.cdc.gov/flu/highrisk/index.htm. Accessed August 10, 2023.
  • Miron VD, Banica L, Sandulescu O, et al. Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season. PLoS One. 2021;16(11):e0258798. doi:10.1371/journal.pone.0258798
  • Andrew MK, Pott H, Staadegaard L, et al. Age differences in comorbidities, presenting symptoms, and outcomes of influenza illness requiring hospitalization: a worldwide perspective from the global influenza hospital surveillance network. Open Forum Infect Dis. 2023;10(6):ofad244. doi:10.1093/ofid/ofad244
  • Sandulescu O, Draganescu A, Pitigoi D. Influenza redefined - clinical and epidemiological insight. Germs. 2019;9(2):60. doi:10.18683/germs.2019.1158
  • Cohen LE, Hansen CL, Andrew MK, et al. Predictors of severity of influenza-related hospitalizations: results from the Global Influenza Hospital Surveillance Network (GIHSN). J Infect Dis. 2023. doi:10.1093/infdis/jiad303
  • Deng Q-Z, Hu A-R, Li H-S. Clinical analysis of 42 obese patients with 2009 pandemic influenza A (H1N1). Dis Surveil. 2010;25(9):713–715.
  • Schreter I, Kristian P, Tkacova R. Obesity and risk of pneumonia in patients with influenza. Eur Respir J. 2011;37(5):1298; author reply 9–300. doi:10.1183/09031936.00188610
  • Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis. 2011;52(3):301–312. doi:10.1093/cid/ciq152
  • Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis. 2011;53(5):413–421. doi:10.1093/cid/cir442
  • Zhao X, Gang X, He G, et al. Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and meta-analysis. Front Endocrinol. 2020;11:595109. doi:10.3389/fendo.2020.595109
  • Yang W, Yang Y, Guo Y, Guo J, Ma M, Han B. Obesity and risk for respiratory diseases: a Mendelian randomization study. Front Endocrinol. 2023;14:1197730. doi:10.3389/fendo.2023.1197730
  • Tarzjani SD, Kamalzadeh S, Moghadam MT, Ashoobi MT. Clinical challenge of co-infection of SARS-CoV-2 with influenza during the influenza circulation season: suggestions for prevention. Germs. 2023;13(2):188–191. doi:10.18683/germs.2023.1384
  • Radu F, Mates I, Gheorghita V. Bucharest mobile military hospital-response to the COVID-19 pandemic. Roman J Mil Med. 2020;123(2):141–147.
  • Arulanandam B, Beladi H, Chakrabarti A. Obesity and COVID-19 mortality are correlated. Sci Rep. 2023;13(1):5895. doi:10.1038/s41598-023-33093-3
  • Onyango TB, Zhou F, Bredholt G, et al. SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients. Front Immunol. 2023;14:1287388. doi:10.3389/fimmu.2023.1287388
  • Singh R, Rathore SS, Khan H, et al. Association of obesity with COVID-19 severity and mortality: an updated systemic review, meta-analysis, and meta-regression. Front Endocrinol. 2022;13:780872. doi:10.3389/fendo.2022.780872
  • Nour TY, Altintas KH. Effect of the COVID-19 pandemic on obesity and it is risk factors: a systematic review. BMC Public Health. 2023;23(1):1018. doi:10.1186/s12889-023-15833-2
  • Anderson LN, Yoshida-Montezuma Y, Dewart N, et al. Obesity and weight change during the COVID-19 pandemic in children and adults: a systematic review and meta-analysis. Obes Rev. 2023;24(5):e13550. doi:10.1111/obr.13550
  • Săndulescu M, Săndulescu O. Changing clinical patterns and ear-nose-throat complications of seasonal viral respiratory tract infections. GERMS. 2023;13(4):311–313.
  • Singla P, Bardoloi A, Parkash AA. Metabolic effects of obesity: a review. World J Diabetes. 2010;1(3):76–88. doi:10.4239/wjd.v1.i3.76
  • Pitigoi D, Nitescu M, Streinu-Cercel A, et al. Characteristics of influenza in elderly patients with and without diabetes, hospitalized for severe acute respiratory infection in a tertiary care hospital from Bucharest Romania - a three-year prospective epidemiological surveillance study. Germs. 2019;9(3):142–147. doi:10.18683/germs.2019.1169
  • Milner JJ, Rebeles J, Dhungana S, et al. Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice. J Immunol. 2015;194(10):4846–4859. doi:10.4049/jimmunol.1402295
  • Arner P, Ryden M. Fatty acids, obesity and insulin resistance. Obes Facts. 2015;8(2):147–155. doi:10.1159/000381224
  • Limsuwat N, Boonarkart C, Phakaratsakul S, Suptawiwat O, Auewarakul P. Influence of cellular lipid content on influenza A virus replication. Arch Virol. 2020;165(5):1151–1161. doi:10.1007/s00705-020-04596-5
  • Hidalgo MA, Carretta MD, Burgos RA. Long chain fatty acids as modulators of immune cells function: contribution of FFA1 and FFA4 receptors. Front Physiol. 2021;12:668330. doi:10.3389/fphys.2021.668330
  • Almond M, Farne HA, Jackson MM, et al. Obesity dysregulates the pulmonary antiviral immune response. Nat Commun. 2023;14(1):6607. doi:10.1038/s41467-023-42432-x
  • Wrzosek M, Zawadzka Z, Sawicka A, Bobrowska-Korczak B, Bialek A. Impact of fatty acids on obesity-associated diseases and radical weight reduction. Obes Surg. 2022;32(2):428–440. doi:10.1007/s11695-021-05789-w
  • Hammad SS, Jones PJ. Dietary fatty acid composition modulates obesity and interacts with obesity-related genes. Lipids. 2017;52(10):803–822. doi:10.1007/s11745-017-4291-9
  • Chandrasekharan JA, Marginean A, Sharma-Walia N. An insight into the role of arachidonic acid derived lipid mediators in virus associated pathogenesis and malignancies. Prostaglandins Other Lipid Mediat. 2016;126:46–54. doi:10.1016/j.prostaglandins.2016.07.009
  • Chandrasekaran R, Morris CR, Butzirus IM, et al. Obesity exacerbates influenza-induced respiratory disease via the arachidonic acid-p38 MAPK pathway. Front Pharmacol. 2023;14:1248873. doi:10.3389/fphar.2023.1248873
  • Yu J, Sun X, Goie JYG, Zhang Y. Regulation of host immune responses against influenza a virus infection by mitogen-activated protein kinases (MAPKs). Microorganisms. 2020;8(7):1067. doi:10.3390/microorganisms8071067
  • Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–863. doi:10.5114/aoms.2016.58928
  • Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101. doi:10.1038/nature13479
  • Pal A, Gowdy KM, Oestreich KJ, Beck M, Shaikh SR. Obesity-driven deficiencies of specialized pro-resolving mediators may drive adverse outcomes during SARS-CoV-2 infection. Front Immunol. 2020;11:1997. doi:10.3389/fimmu.2020.01997
  • Pascoal LB, Bombassaro B, Ramalho AF, et al. Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity. J Neuroinflammation. 2017;14(1):5. doi:10.1186/s12974-016-0777-2
  • Puliani G, Sbardella E, Cozzolino A, et al. Pituitary T1 signal intensity at magnetic resonance imaging is reduced in patients with obesity: results from the CHIASM study. Int J Obes. 2023;1:4.
  • Berczi I. Pituitary hormones and immune function. Acta Paediatr Suppl. 1997;423:70–75. doi:10.1111/j.1651-2227.1997.tb18376.x
  • Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab. 2016;20(4):554–557. doi:10.4103/2230-8210.183454
  • Valli E, Dalotto-Moreno T, Sterle HA, et al. Hypothyroidism-associated immunosuppression involves induction of galectin-1-producing regulatory T cells. FASEB J. 2023;37(4):e22865. doi:10.1096/fj.202200884R
  • Akalestou E, Genser L, Rutter GA. Glucocorticoid metabolism in obesity and following weight loss. Front Endocrinol. 2020;11:59. doi:10.3389/fendo.2020.00059
  • Fui MN, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014;16(2):223–231. doi:10.4103/1008-682X.122365
  • Kelly DM, Jones TH. Testosterone and obesity. Obes Rev. 2015;16(7):581–606. doi:10.1111/obr.12282
  • Tuku B, Stanelle-Bertram S, Sellau J, et al. Testosterone protects against severe influenza by reducing the pro-inflammatory cytokine response in the murine lung. Front Immunol. 2020;11:697. doi:10.3389/fimmu.2020.00697
  • Vom Steeg LG, Vermillion MS, Hall OJ, et al. Age and testosterone mediate influenza pathogenesis in male mice. Am J Physiol Lung Cell Mol Physiol. 2016;311(6):L1234–L1244. doi:10.1152/ajplung.00352.2016
  • Ayari A, Rosa-Calatrava M, Lancel S, et al. Influenza infection rewires energy metabolism and induces browning features in adipose cells and tissues. Commun Biol. 2020;3(1):237. doi:10.1038/s42003-020-0965-6
  • Guglielmi V, Colangeli L, D’Adamo M, Sbraccia P. Susceptibility and severity of viral infections in obesity: lessons from influenza to COVID-19. Does leptin play a role? Int J Mol Sci. 2021;22(6):3183. doi:10.3390/ijms22063183
  • Zhang AJ, To KK, Li C, et al. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. J Infect Dis. 2013;207(8):1270–1280. doi:10.1093/infdis/jit031
  • Johnson AR, Milner JJ, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev. 2012;249(1):218–238. doi:10.1111/j.1600-065X.2012.01151.x
  • Paich HA, Sheridan PA, Handy J, et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity. 2013;21(11):2377–2386. doi:10.1002/oby.20383
  • Honce R, Schultz-Cherry S. Impact of obesity on influenza a virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10:1071. doi:10.3389/fimmu.2019.01071
  • O’Brien KB, Vogel P, Duan S, et al. Impaired wound healing predisposes obese mice to severe influenza virus infection. J Infect Dis. 2012;205(2):252–261. doi:10.1093/infdis/jir729
  • Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol. 2009;9(4):447–453. doi:10.1016/j.coph.2009.04.008
  • Muhl H, Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol. 2003;3(9):1247–1255. doi:10.1016/S1567-5769(03)00131-0
  • Maier HE, Lopez R, Sanchez N, et al. Obesity increases the duration of influenza a virus shedding in adults. J Infect Dis. 2018;218(9):1378–1382. doi:10.1093/infdis/jiy370
  • Honce R, Karlsson EA, Wohlgemuth N, et al. Obesity-related microenvironment promotes emergence of virulent influenza virus strains. mBio. 2020;11(2). doi:10.1128/mBio.03341-19
  • Knoll M, Honce R, Meliopoulos V, Schultz-Cherry S, Ghedin E, Gresham D. Host obesity impacts genetic variation in influenza A viral populations. bioRxiv. 2023. doi:10.1101/2023.07.12.548715
  • Honce R, Jones J, Meliopoulos VA, et al. Efficacy of oseltamivir treatment in influenza virus-infected obese mice. mBio. 2023;14(4):e0088723. doi:10.1128/mbio.00887-23
  • Alsuwailem SI, Okmi EA, Alkhaldi EH, Almutairi KS, Alshamari WK. Determinants of flu vaccine uptake among the general population in Saudi Arabia: a study based on the health belief model. Cureus. 2023;15:7.
  • Szollosi GJ, Minh NC, Santoso CMA, Zsuga J, Nagy AC, Kardos L. An exploratory assessment of factors with which influenza vaccine uptake is associated in Hungarian adults 65 years old and older: findings from European health interview surveys. Int J Environ Res Public Health. 2022;19(12):7545. doi:10.3390/ijerph19127545
  • Karachaliou M, Damianaki I, Moudatsaki M, et al. Influenza vaccination coverage rates and determinants in Greek children until the age of ten (2008–2019), the rhea mother-child cohort. Vaccines. 2023;11(7):1241. doi:10.3390/vaccines11071241
  • Strouthou E, Karageorgos SA, Christaki E, Agouridis AP, Tsioutis C. Medical students’ attitudes and perceptions of influenza and SARS-CoV-2 vaccination in Cyprus. Germs. 2022;12(2):180–194. doi:10.18683/germs.2022.1321
  • Wiggins KB, Smith MA, Schultz-Cherry S. The nature of immune responses to influenza vaccination in high-risk populations. Viruses. 2021;13(6):1109. doi:10.3390/v13061109
  • Mungmunpuntipantip R, Wiwanitkit V. Comment on ”Medical students’ attitudes and perceptions of influenza and SARS-CoV-2 vaccination in Cyprus”. Germs. 2023;13(2):192–193. doi:10.18683/germs.2023.1385
  • Kim YH, Kim JK, Kim DJ, et al. Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model. J Infect Dis. 2012;205(2):244–251. doi:10.1093/infdis/jir731
  • Park HL, Shim SH, Lee EY, et al. Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine. Hum Vaccin Immunother. 2014;10(5):1181–1186. doi:10.4161/hv.28332
  • Frasca D, Romero M, Diaz A, Blomberg BB. Obesity accelerates age defects in B cells, and weight loss improves B cell function. Immun Ageing. 2023;20(1):35. doi:10.1186/s12979-023-00361-9
  • Neidich SD, Green WD, Rebeles J, et al. Increased risk of influenza among vaccinated adults who are obese. Int J Obes. 2017;41(9):1324–1330. doi:10.1038/ijo.2017.131
  • Esposito S, Giavoli C, Trombetta C, et al. Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children. Vaccine. 2016;34(1):56–60. doi:10.1016/j.vaccine.2015.11.019
  • Clarke M, Mathew SM, Giles LC, et al. A prospective study investigating the impact of obesity on the immune response to the quadrivalent influenza vaccine in children and adolescents. Vaccines. 2022;10(5):5. doi:10.3390/vaccines10050699